These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 20840149)

  • 21. FR167653, a p38 mitogen-activated protein kinase inhibitor, prevents Helicobacter pylori-induced gastritis in Mongolian gerbils.
    Takahashi S; Keto Y; Fujita T; Uchiyama T; Yamamoto A
    J Pharmacol Exp Ther; 2001 Jan; 296(1):48-56. PubMed ID: 11123361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility of Helicobacter pylori to metronidazole.
    Perna F; Gatta L; Figura N; Ricci C; Tampieri A; Holton J; Miglioli M; Vaira D
    Am J Gastroenterol; 2003 Oct; 98(10):2157-61. PubMed ID: 14572561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marked reduction of Helicobacter pylori-induced gastritis by urease inhibitors, acetohydroxamic acid and flurofamide, in Mongolian gerbils.
    Ohta T; Shibata H; Kawamori T; Iimuro M; Sugimura T; Wakabayashi K
    Biochem Biophys Res Commun; 2001 Jul; 285(3):728-33. PubMed ID: 11453654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastric mucosal cytokine and epithelial cell responses to Helicobacter pylori infection in Mongolian gerbils.
    Crabtree JE; Court M; Aboshkiwa MA; Jeremy AH; Dixon MF; Robinson PA
    J Pathol; 2004 Feb; 202(2):197-207. PubMed ID: 14743502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of Helicobacter pylori infection on gastric mucosal cell proliferation in Mongolian gerbils].
    Yao YL; Xu B; Song YG; Zhang WD; Zhang YL; Zhang ZS
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):348-50, 365. PubMed ID: 12390744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pitavastatin fails to lower serum lipid levels or inhibit gastric carcinogenesis in helicobacter pylori-infected rodent models.
    Toyoda T; Tsukamoto T; Takasu S; Hirano N; Ban H; Shi L; Kumagai T; Tanaka T; Tatematsu M
    Cancer Prev Res (Phila); 2009 Aug; 2(8):751-8. PubMed ID: 19622613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Helicobacter pylori infection and gastric diseases--pathogenesis and effects of eradication].
    Matsukura N
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1341-9. PubMed ID: 12214459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amoxicillin for the treatment of Helicobacter pylori infection.
    Hirschl AM; Rotter ML
    J Gastroenterol; 1996 Nov; 31 Suppl 9():44-7. PubMed ID: 8959518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection against Helicobacter pylori infection in mongolian gerbil by intragastric or intramuscular administration of H. pylori multicomponent vaccine.
    Wu C; Shi Y; Guo H; Zou WY; Guo G; Xie QH; Mao XH; Tong WD; Zou QM
    Helicobacter; 2008 Jun; 13(3):191-9. PubMed ID: 18466394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial activity of aminoreductone against Helicobacter pylori.
    Trang VT; Takeuchi H; Kudo H; Aoki A; Katsuno S; Shimamura T; Sugiura T; Ukeda H
    J Agric Food Chem; 2009 Dec; 57(23):11343-8. PubMed ID: 19891477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative proteomics analysis of Helicobacter pylori after adaptive colonization in Mongolian gerbils].
    Guo G; Tong WD; Zeng H; Liu KY; Zou QM
    Wei Sheng Wu Xue Bao; 2007 Jun; 47(3):461-4. PubMed ID: 17672306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo activities of tea catechins against Helicobacter pylori.
    Mabe K; Yamada M; Oguni I; Takahashi T
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1788-91. PubMed ID: 10390246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of in vitro biofilm formation by Helicobacter pylori.
    Yonezawa H; Osaki T; Kurata S; Zaman C; Hanawa T; Kamiya S
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S90-4. PubMed ID: 20586874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The oligo-acyl lysyl antimicrobial peptide C₁₂K-2β₁₂ exhibits a dual mechanism of action and demonstrates strong in vivo efficacy against Helicobacter pylori.
    Makobongo MO; Gancz H; Carpenter BM; McDaniel DP; Merrell DS
    Antimicrob Agents Chemother; 2012 Jan; 56(1):378-90. PubMed ID: 22064541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atractylodes lancea volatile oils attenuated helicobacter pylori NCTC11637 growth and biofilm.
    Yu M; Wang X; Ling F; Wang H; Zhang P; Shao S
    Microb Pathog; 2019 Oct; 135():103641. PubMed ID: 31330262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo action of novel alkyl methyl quinolone alkaloids against Helicobacter pylori.
    Tominaga K; Higuchi K; Hamasaki N; Hamaguchi M; Takashima T; Tanigawa T; Watanabe T; Fujiwara Y; Tezuka Y; Nagaoka T; Kadota S; Ishii E; Kobayashi K; Arakawa T
    J Antimicrob Chemother; 2002 Oct; 50(4):547-52. PubMed ID: 12356800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does long-term use of silver nanoparticles have persistent inhibitory effect on H. pylori based on Mongolian gerbil's model?
    Kuo CH; Lu CY; Yang YC; Chin C; Weng BC; Liu CJ; Chen YH; Chang LL; Kuo FC; Wu DC; Su HL
    Biomed Res Int; 2014; 2014():461034. PubMed ID: 24864246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of novel nanoparticles shelled with heparin for berberine delivery to treat Helicobacter pylori.
    Chang CH; Huang WY; Lai CH; Hsu YM; Yao YH; Chen TY; Wu JY; Peng SF; Lin YH
    Acta Biomater; 2011 Feb; 7(2):593-603. PubMed ID: 20813208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Helicobacter pylori is a fragile bacteria when stored at low and ultra-low temperatures.
    Ohkusa T; Miwa H; Endo S; Okayasu I; Sato N
    J Gastroenterol Hepatol; 2004 Feb; 19(2):200-4. PubMed ID: 14731131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro bactericidal effects of near-ultraviolet light from light-emitting diodes on Helicobacter pylori.
    Okamoto T; Nishikawa J; Yanai H; Nakamura H; Takeuchi H; Kurai S; Akada JK; Sakaida I
    Scand J Gastroenterol; 2013 Dec; 48(12):1484-6. PubMed ID: 24063529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.